An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension

  1. Simon, M.A.
  2. Hanrott, K.
  3. Budd, D.C.
  4. Torres, F.
  5. Grünig, E.
  6. Escribano-Subias, P.
  7. Meseguer, M.L.
  8. Halank, M.
  9. Opitz, C.
  10. Hall, D.A.
  11. Hewens, D.
  12. Powley, W.M.
  13. Siederer, S.
  14. Bayliffe, A.
  15. Lazaar, A.L.
  16. Cahn, A.
  17. Rosenkranz, S.
Revue:
Pulmonary Circulation

ISSN: 2045-8940,  2045-8932

Année de publication: 2022

Volumen: 12

Número: 1

Type: Article

DOI: 10.1002/PUL2.12024 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus